Salvage High-Dose-Rate Brachytherapy for Recurrent Prostate Cancer After Definitive Radiation
Author:
Funder
National Institute of Biomedical Imaging and Bioengineering
National Institutes of Health
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology
Reference50 articles.
1. Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer
2. Prostate cancer and radiation therapy—The message conveyed by serum prostate-specific antigen;Zagars;Int J Radiat Oncol Biol Phys,1995
3. Anatomical patterns of recurrence following biochemical relapse in the dose escalation era of external beam radiotherapy for prostate cancer;Zumsteg;J Urol,2015
4. 68 Ga-PSMA-PET/CT staging prior to definitive radiation treatment for prostate cancer;Hruby;Asia Pac J Clin Oncol,2018
5. Detection efficacy of hybrid 68Ga-PSMA ligand PET/CT in prostate cancer patients with biochemical recurrence after primary radiation therapy defined by Phoenix criteria;Einspieler;J Nucl Med,2017
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Systematic review and recommendations for re-irradiation for intraprostatic radiorecurrent prostate cancer after definitive radiation therapy;World Journal of Urology;2024-09-12
2. Protocol-based CT-guided brachytherapy for patients with prostate cancer and previous rectal extirpation—a curative approach;Strahlentherapie und Onkologie;2024-08-02
3. Controversies in prostate cancer management: Consensus recommendations from experts in northern Spain;Actas Urológicas Españolas (English Edition);2024-07
4. Controversias en el abordaje del cáncer de próstata: consenso de recomendaciones de expertos del norte de España;Actas Urológicas Españolas;2024-06
5. Evaluation of the safety and efficacy of high-dose rate brachytherapy for radiorecurrent prostate cancer: a systematic review and meta-analysis;Strahlentherapie und Onkologie;2024-02-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3